[{"Assets_0_Q1_USD":676596000.0,"CommonStockSharesOutstanding_0_Q1_shares":95257705.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-30323000.0,"NetIncomeLoss_1_Q1_USD":-38992000.0,"StockholdersEquity_0_Q1_USD":516648000.0,"Ticker":"DNLI","CIK":"1714899","name":"DENALI THERAPEUTICS INC.","OfficialName":"Denali Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3477413158.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190508"}]